Bringing Cancer Prevention to Scale: The Role of Alcohol Policy and Awareness
Alcohol Issues Special Edition Newsletter on World Cancer Day
Perspectives: Opportunities to Tackle Cancer Through Alcohol Policy and Awareness
A quiet but consequential shift is underway in cancer prevention – and Colombia is showing an inspiring example. In a landmark institutional move, the National Cancer Institute of Colombia has placed alcohol explicitly on its cancer prevention agenda, treating it as what the science has long established: an avoidable carcinogen shaped by commercial and policy environments.
In a headline opinion column for World Cancer Day, María Isabel Calderón offers an inside account of how the Institute adopted a commercial determinants of health lens – aligning evidence, public policy, and community mobilisation to close the gap between what is known about alcohol and cancer and what governments actually do. As Colombia debates pro-health taxes, the message is unambiguous: cancer prevention advances when protecting lives takes precedence over protecting profits.
This shift resonates far beyond Colombia. Across the Caribbean, new data show alcohol driving a growing cancer and noncommunicable disease burden, exacerbated by sustained alcohol industry interference and policy inertia. As Maik Dünnbier writes, regional cooperation and people-powered advocacy are beginning to change the political calculus – demonstrating that evidence-based alcohol policy can advance health, social justice, and development at the same time.
At the personal and community level, the silence around alcohol’s cancer risks remains deadly. Amy C. Willis confronts the persistent information gap on alcohol and breast cancer, combining lived experience with state-of-the-art evidence to show how women are systematically underserved by awareness campaigns that omit a major, preventable risk factor. The absence of clear information is not accidental – it reflects whose interests are prioritised: alcohol industry instead of women’s right to know.
Kristina Šperková brings these threads together, making the case that a genuinely people-centred response to cancer needs to address alcohol. From prevention and early detection to equity and survivorship, addressing alcohol exposure is essential to delivering cancer systems that are fair, effective, and responsive to real-world risks.
Taken together, these perspectives highlight alcohol and cancer as health issue, as well as a governance issue, a justice issue, and a test of whether public policy is guided by evidence and people’s rights – or limited by commercial interests.
The opportunity now is to align alcohol policy with cancer science and people’s lived realities – delivering prevention that is timely, effective, and fair.
Preventing Cancer at Scale: The Potential of Alcohol Taxation
Alcohol tax policy is where cancer prevention delivers results at scale. A growing body of independent scientific modelling shows a compelling case: raising alcohol excise taxes prevents cancer cases and saves lives – quickly, measurably, and equitably.
Cancer cases due to alcohol remain staggering: an estimated 21,980 cases in Germany, 10,006 in Italy, 1,655 in Kazakhstan, and 1,416 in Sweden in a single year. Modelling shows that increasing alcohol excise taxes could avert 3–7% of these cancers, with the largest gains in countries where taxes remain lowest. In Germany alone, higher alcohol taxes would have prevented hundreds of cancer cases in one year – without new technologies, new clinics, or long time horizons.
The implications widen when scaled regionally. Doubling alcohol excise taxes across the WHO European Region could prevent almost 6% of all alcohol-caused cancer cases and deaths – translating into 180,900 fewer cancer cases and 85,100 lives saved. These gains are particularly pronounced in EU Member States, where alcohol taxation has lagged far behind the evidence for decades.
The evidence is just as clear in the United States. Analyses of national cancer mortality data show that strong alcohol policy – including taxation – could prevent the vast majority of cancer deaths caused by alcohol, especially when combined with population-level reductions in alcohol availability. The benefits accrue fastest among people currently carrying the highest risk. This highlights alcohol taxation as both a public health and equity measures.
That is why cancer prevention leaders are increasingly explicit. In our recent conversation with Kendra Chow of World Cancer Research Fund International, the message was direct: governments already possess one of the most powerful cancer-prevention tools available. The barrier is not evidence – it is political will, shaped by commercial pressure and misplaced caution.
Read together with the opinion columns in this special edition – from Colombia’s National Cancer Institute to the Caribbean, from women’s lived experience to people-centred cancer care – the conclusion is clear: alcohol taxation is a frontline cancer-prevention solution.
Making the Alcohol-Cancer Link Visible
Cancer prevention starts with who controls information – and whether people are told the truth early enough to act. Across countries, evidence now shows that clear warnings about alcohol’s cancer risk can break through decades of alcohol industry misinformation and begin to change behaviour, norms, and policy expectations.
In the United States, public awareness of alcohol’s cancer risk is rising sharply. A national survey shows that 56% of adults now recognise that regular alcohol use increases cancer risk, up from just 40% months earlier. This shift follows a January 2025 advisory from the U.S. Surgeon General calling for updated alcohol warning labels. It is a reminder that when trusted public institutions speak clearly, misinformation loses ground – even in markets long shaped by alcohol industry narratives.
But awareness alone is not enough. New experimental evidence from Chile shows why warning labels matter – and which ones work. In the first large randomized study of its kind, cancer-related warnings significantly reduced alcohol selection across population groups. General health warnings outperformed targeted messaging, reinforcing a key lesson for policymakers: simple, direct cancer warnings change behaviour.
Crucially, research also shows where the process can stall. Studies examining the pathway from awareness to policy support find that knowing alcohol causes cancer is different from accepting it. Where alcohol industry doubt-casting and misinformation persist, awareness fails to translate into public backing for life-saving alcohol policy. Acceptance of the science – not just exposure to information – is the enabling condition for action.
Comparative analysis shows that jurisdictions adopting clear on-product cancer warnings, updated low-risk guidelines, and sustained public education are better equipped to close the gap between evidence and prevention. It also exposes an insidious counter-force to people’s right to know: alcohol industry efforts to keep people in the dark about the cancer risk of their own products.
Read alongside the opinion columns in this special edition – from Colombia’s National Cancer Institute reframing alcohol as a cancer prevention issue, to women demanding honest information about breast cancer risk, to calls for people-centred cancer care, the message is clear: Increasing the recognition of the direct link between alcohol and cancer is about correcting a structural information failure. And once people know – and believe – the truth, the politics of prevention begins to change.
World Class Science to Understand Cancer Burden Caused by Alcohol
The science has become decisive and impossible to ignore.
A major new global analysis led by the World Health Organization and its cancer agency, the International Agency for Research on Cancer, identifies alcohol as the third leading preventable cause of cancer worldwide, behind only tobacco and excess body weight.
The study estimates that 37% of all new cancer cases globally – more than 7 million in 2022 – were caused by preventable factors, placing alcohol policy squarely among the most powerful levers for cancer prevention.
New data from the Global Burden of Disease study sharpen that picture further. According to the Institute for Health Metrics and Evaluation, healthy life years lost due to alcohol-attributable cancer have increased by 11% globally since 2006 – even as governments claim progress on noncommunicable diseases. In multiple regions, the trend is accelerating. Countries such as Vietnam, Nepal, and Kenya have seen dramatic rises in cancer burden linked to alcohol. Across Asia, Eastern Europe, and much of the Americas, alcohol-related cancer harm continues to climb, including in high-income countries where baseline burdens are already among the world’s highest.
Cross-country analysis illustrates that this is a global issue. Comparative studies covering Brazil, China, India, Russia, South Africa, the United Kingdom, and the United States show alcohol alongside tobacco, excess body weight, and infections as a major driver of cancer deaths and years of life lost. The mix varies by country, but the conclusion does not: cancer prevention without addressing alcohol is inadequate.
Cancer burden due to alcohol is also economic. New research estimates that premature cancer deaths caused by alcohol cost the European Union €4.6 billion annually in lost productivity alone – a figure never previously calculated. These are losses borne by families, workplaces, and public budgets, long before treatment costs are counted. Prevention, the authors conclude, is economically imperative.
Taken together, the science points to a powerful opportunity. Cancer caused by alcohol is preventable, effective solutions are already available, and acting on them can rapidly prevent human suffering. Aligning public policy with evidence, people’s rights, and the real scale of the cancer burden offers a clear path to improved prevention, fairer outcomes, and healthier communities.